The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 02, 2024
Filed:
Oct. 03, 2017
Applicant:
Sigilon Therapeutics, Inc., Cambridge, MA (US);
Inventors:
Omid Veiseh, Bellaire, TX (US);
Richard Heidebrecht, Somerville, MA (US);
Paul Kevin Wotton, Boston, MA (US);
Matthias Alexander Oberli, Cambridge, MA (US);
Robert James Miller, East Bridgewater, MA (US);
Assignee:
SIGILON THERAPEUTICS, INC., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4192 (2006.01); A61K 9/00 (2006.01); A61K 31/05 (2006.01); A61K 31/54 (2006.01); A61K 31/541 (2006.01); A61K 31/695 (2006.01); A61K 31/7056 (2006.01); A61K 35/30 (2015.01); A61K 38/47 (2006.01); A61K 39/395 (2006.01); A61P 3/00 (2006.01); A61P 7/02 (2006.01); A61P 7/04 (2006.01); A61P 37/00 (2006.01); A61P 37/04 (2006.01); A61P 37/06 (2006.01); A61P 43/00 (2006.01); C07D 249/04 (2006.01); C07D 249/06 (2006.01); C07D 295/088 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 409/04 (2006.01); C07F 7/18 (2006.01); C07H 15/26 (2006.01); C07K 16/22 (2006.01); C12N 9/40 (2006.01);
U.S. Cl.
CPC ...
C07D 249/04 (2013.01); A61K 9/0019 (2013.01); A61K 31/4192 (2013.01); A61K 31/54 (2013.01); A61K 31/541 (2013.01); A61K 31/695 (2013.01); A61K 31/7056 (2013.01); A61K 35/30 (2013.01); A61K 38/47 (2013.01); A61K 39/3955 (2013.01); A61P 37/04 (2018.01); A61P 37/06 (2018.01); C07D 295/088 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01); C07F 7/1804 (2013.01); C07F 7/1892 (2013.01); C07H 15/26 (2013.01); C07K 16/22 (2013.01); C12N 9/2465 (2013.01); C12Y 302/01022 (2013.01);
Abstract
The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are implantable elements (e.g., devices and materials) comprising the same, as well as methods of use thereof, e.g., for treating or preventing a disease, disorder, or condition.